Zobrazeno 1 - 10
of 42
pro vyhledávání: '"James Raschko"'
Autor:
Sidney A. Scudder, Eddie Reed, Lucille Leong, Stephen Shibata, Kim Margolin, Steven A. Vasilev, James Raschko, Jeffrey Longmate, George Somlo, David R. Gandara, Merry Tetef, Robert J. Morgan, James H. Doroshow, Mary Carroll, Timothy W. Synold, Franco M. Muggia, Yun Yen, Warren Chow, Kathryn F. McGonigle
Publikováno v:
International Journal of Gynecologic Cancer. 17:373-378
The purpose of this study was to estimate the response rate of 26-h continuous infusion cyclosporine A (CSA) combined with carboplatin (CBDCA) and subcutaneous alpha-interferon (IFN), in recurrent ovarian cancer (OC), and to measure their effects on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf2e64f1c0d4aca6104cacf92de36bc
https://doi.org/10.1111/j.1525-1438.2007.00787.x
https://doi.org/10.1111/j.1525-1438.2007.00787.x
Autor:
Steven A. Vasilev, George Somlo, Kim Margolin, Lucille Leong, Kathryn F. McGonigle, James Raschko, Timothy W. Synold, Jeff Longmate, David R. Gandara, Yun Yen, Franco M. Muggia, Eddie Reed, Robert J. Morgan, Sidney A. Scudder, Stephen Shibata, Mary Carroll, Warren Chow, James H. Doroshow, Merry Tetef
Publikováno v:
Cancer Chemotherapy and Pharmacology. 54:283-289
To determine the response rate to 26-h continuous infusion cyclosporine A (CSA) combined with a fixed dose level of carboplatin (CBDCA) in patients with recurrent ovarian cancer, and to determine the effect of CSA on the pharmacokinetics of CBDCA.To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f54954125837907d33b0a78df7115a
https://doi.org/10.1007/s00280-004-0818-x
https://doi.org/10.1007/s00280-004-0818-x
Autor:
Warren Chow, Yun Yen, Merry Tetef, George Somlo, Timothy W. Synold, Przemyslaw Twardowski, James Raschko, Zaid Al-Khadimi, Lucille Leong, Dean Lim, Stephen Shibata, James H. Doroshow, Joyce Lawrence, Paul Frankel, Jeffrey Longmate, Robert J. Morgan, Kim Margolin
Publikováno v:
Cancer Chemotherapy and Pharmacology. 54:241-248
Dexrazoxane administration prior to short infusion doxorubicin prevents anthracycline-related heart damage. Since delivery of doxorubicin by 96-h continuous intravenous infusion also reduces cardiac injury, we studied delivering dexrazoxane and doxor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ff559cb05401de1540ccf7f9dc9f55
https://doi.org/10.1007/s00280-004-0803-4
https://doi.org/10.1007/s00280-004-0803-4
Autor:
Neil Kogut, Arturo Molina, Stephen Shibata, Lucille Leong, Warren Chow, Mark McNamara, J F Simpson, Kim Margolin, James H. Doroshow, James Raschko, Stephen J. Forman, E Somlo, George Somlo, Robert J. Morgan, Paul Frankel
Publikováno v:
British Journal of Cancer
We report on a predictive model of long-term outcome in 114 high-risk breast cancer patients treated with high-dose chemotherapy between 1989 and 1994. Paraffin-blocks from 90 of the 114 primaries were assessed for the presence of five risk factors:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0392c9957dead1d7a43248899b916dab
https://doi.org/10.1038/sj.bjc.6600450
https://doi.org/10.1038/sj.bjc.6600450
Autor:
Primo N. Lara, Derick H Lau, Jeff Longmate, Paul Frankel, Heinz-Josef Lenz, Edith A. Perez, Regina F Gandour-Edwards, James Raschko, David R. Gandara, James H. Doroshow, Paul H. Gumerlock, Philip C. Mack, Martin J. Edelman, Valerie Israel
Publikováno v:
Cancer Chemotherapy and Pharmacology. 48:22-28
Purpose: Although cisplatin is an important agent in non-small-cell lung cancer (NSCLC), de novo resistance is common and acquired resistance emerges rapidly during therapy. Proposed mediators of platinum resistance include the protein kinase C (PKC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e111e9a8784fd66ee2f8f27183dd6c
https://doi.org/10.1007/s002800100293
https://doi.org/10.1007/s002800100293
Autor:
Eileen P. Smith, Robert J. Morgan, James Raschko, Irena Sniecinski, James H. Doroshow, Stephen J. Forman, Yun Yen, George Somlo, Margaret R. O'Donnell, Paul Frankel, Kim Margolin, Jeff Longmate, Debbie Reardon, Lucille Leong, Stephen Shibata, Arturo Molina, Merry Tetef, Warren Chow, Victor Hamasaki
Publikováno v:
Scopus-Elsevier
We evaluated the feasibility of tandem-cycle high-dose chemotherapy (HDCT) with cisplatin, melphalan, and peripheral blood progenitor cells (PBPCs). Fifty patients with high-risk primary (n = 17) or stage IV breast cancer (n = 29) or other malignanci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cde87dddc7833c9bbb413c9b4224448
Autor:
Neil Kogut, Joseph C. Alvarnas, Kim Margolin, Yun Yen, Jeffrey Longmate, James Raschko, George Somlo, Stephen J. Forman, J. Schriber, James H. Doroshow, David A. Reardon, Merry Tetef, Stephen Shibata, Lucille Leong, Warren Chow, Timothy W. Synold, Robert J. Morgan
Publikováno v:
British Journal of Cancer
We assessed the feasibility and pharmacokinetics of high-dose infusional paclitaxel in combination with doxorubicin, cyclophosphamide, and peripheral blood progenitor cell rescue. Between October 1995 and June 1998, 63 patients with high-risk primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567b96ed4666cbde3b22598e1113fcf4
https://doi.org/10.1054/bjoc.2001.1835
https://doi.org/10.1054/bjoc.2001.1835
Autor:
James Raschko, Mary Carroll, Steven A. Akman, Robert J. Morgan, Lucille Leong, Jeffrey Longmate, Edward M. Newman, Neil Slatkin, Kim Margolin, George Somlo, James H. Doroshow, Merry Tetef
Publikováno v:
Cancer Chemotherapy and Pharmacology. 46:19-26
Purpose: To evaluate the pharmacokinetics and toxicity of high-dose intravenous (i.v.) methotrexate (MTX) with leucovorin in patients with meningeal carcinomatosis. Methods: Of 16 eligible patients entered on this study, 13 with meningeal carcinomato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154913cc5e80286c52e66857c2769b88
https://doi.org/10.1007/s002800000118
https://doi.org/10.1007/s002800000118
Autor:
Irena Sniecinski, Jeffrey Longmate, Stephen J. Forman, Warren Chow, Stephen Shibata, Mark Ashby, Gaylord J. Knutson, Lucille Leong, Merry Tetef, Susan Hellmann, Yun Yen, James Raschko, Anna ter Veer, George Somlo, Robert J. Morgan, Ravi Bhatia, Gwen Fyfe, James H. Doroshow, Stanimir Vuk-Pavlović, Dennie Jones, Kim Margolin
Publikováno v:
Blood. 93:2798-2806
Lineage-specific growth factors mobilize peripheral blood progenitor cells (PBPC) and accelerate hematopoietic recovery after high-dose chemotherapy. Recombinant human thrombopoietin (rhTPO) may further increase the progenitor-cell content and regene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab58c06620e9b3208109247b76264a15
https://doi.org/10.1182/blood.v93.9.2798
https://doi.org/10.1182/blood.v93.9.2798
Autor:
Vicki Frigerio, Richard Payne, Michael A. Busch, Jane M. Ingham, Russell K. Portenoy, Alan P. Lyss, Michelle Rhiner, Paul Coluzzi, Diane B. Loseth, James Raschko, Earl Nordbrock
Publikováno v:
Pain. 79:303-312
Oral transmucosal fentanyl citrate (OTFC) is a novel opioid formulation in which the potent synthetic mu-agonist fentanyl is embedded in a sweetened matrix that is dissolved in the mouth. It is undergoing investigation as a treatment for cancer-relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a864c18e25377410fa9b4dc0f438ab6
https://doi.org/10.1016/s0304-3959(98)00179-1
https://doi.org/10.1016/s0304-3959(98)00179-1